Earnings call briefThird-quarter 2026

Hims & Hers Health HIMS

Hims & Hers Health expects at least $650 million of international revenue in 2026

The company said its reduced Adjusted EBITDA guidance reflects more aggressive pricing and marketing in the U.K. and Germany and the membership deferral.

GetSignal

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Hims & Hers Health said on its third-quarter call that the weight loss membership deferral will reduce 2026 revenue and Adjusted EBITDA by at least $20 million for the full year. The company said certain membership payments received in December will not be recognized as revenue until January.

Chief Financial Officer Yemi Okupe also said the company expects positive free cash flow for the full year of 2026.

Quotes from the call

“Our expectation is that our international business delivers at least $650 million of revenue in 2026, up from our prior expectation of $600 million.”

Yemi Okupe, Chief Financial Officer

Key facts from the call

Company's 2026 international revenue outlook
At least $650 million, up from $600 million
Expected weight loss membership deferral impact, full year 2026
Reduces revenue and Adjusted EBITDA by at least $20 million
Expected 2026 free cash flow
Positive

All HIMS call briefs

Source: Hims & Hers Health's third-quarter 2026 earnings call, November 9, 2026.

Written by GetSignal with AI from the company's earnings call.

Not investment advice.

More earnings call briefs

Hims & Hers Health first, then the newest

All earnings call briefs